Is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing?

Ann Allergy Asthma Immunol. 2022 Dec;129(6):667-668. doi: 10.1016/j.anai.2022.09.001.
No abstract available

Publication types

  • Editorial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • COVID-19 / prevention & control
  • COVID-19 Vaccines* / administration & dosage
  • Humans
  • Vaccine Excipients*

Substances

  • COVID-19 Vaccines
  • Vaccine Excipients